Effects of the FGF receptor‐1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Effects of the FGF receptor‐1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension

Published:2019-12 Issue:23 Volume:176 Page:4462-4473
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Felix Nathane Santanna¹²,Mendonça Lucas¹²,Braga Cassia Lisboa¹²,Silva Jaqueline Soares³,Samary Cynthia dos Santos¹²,Vieira Juliana Borges¹²,Cruz Fernanda¹²,Rocha Nazareth de Novaes¹²⁴,Zapata‐Sudo Gisele³,Rocco Patricia Rieken Macedo¹²,Silva Pedro Leme¹²^ORCID

Affiliation:

1. Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Institute of Public Health StudiesFederal University of Rio de Janeiro Rio de Janeiro Brazil

2. National Institute of Science and Technology for Regenerative Medicine Rio de Janeiro Brazil

3. Laboratory of Cardiovascular PharmacologyFederal University of Rio de Janeiro Rio de Janeiro Brazil

4. Physiology and Pharmacology DepartmentFluminense Federal University Rio de Janeiro Brazil

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14807

Reference44 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors

2. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

3. Elevated Basic Fibroblast Growth Factor Levels in Patients With Pulmonary Arterial Hypertension

4. TGF-β signaling in fibrosis

5. Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effects of hypoxia-preconditioned bone marrow-derived mesenchymal stromal cells and their extracellular vesicles in experimental pulmonary arterial hypertension;Life Sciences;2023-09

2. Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells;American Journal of Cardiovascular Drugs;2023-07-31

3. Infigratinib, a Selective Fibroblast Growth Factor Receptor Inhibitor, Suppresses Stent-Induced Tissue Hyperplasia in a Rat Esophageal Model;CardioVascular and Interventional Radiology;2023-07-25

4. Pulmonary Vascular Remodeling in Pulmonary Hypertension;Journal of Personalized Medicine;2023-02-19

5. Sildenafil prevents right ventricular hypertrophy and improves heart rate variability in rats with pulmonary hypertension secondary to experimental diabetes;Clinical and Experimental Hypertension;2022-03-20